Search

Progyny Inc

Slēgts

SektorsVeselības aprūpe

27.76 1.5

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

27.25

Max

27.44

Galvenie mērījumi

By Trading Economics

Ienākumi

28M

52M

Pārdošana

22M

351M

P/E

Sektora vidējais

28.196

56.597

EPS

0.34

Peļņas marža

14.917

Darbinieki

835

EBITDA

5.9M

44M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+24.98% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 5. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-448M

2B

Iepriekšējā atvēršanas cena

26.26

Iepriekšējā slēgšanas cena

27.76

Ziņu noskaņojums

By Acuity

40%

60%

96 / 339 Rangs Healthcare

Progyny Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 11. sept. 20:08 UTC

Progyny Inc shares are higher during Friday's session, despite no specific news. The broader market has closed lower, reflecting a cumulative gain since Thursday.

2026. g. 10. sept. 20:07 UTC

Progyny Inc shares are lower today amid broader market declines and rising Treasury yields. No specific company news has been identified to explain the move.

2026. g. 9. sept. 20:07 UTC

Progyny Inc shares are lower in Wednesday trading, reflecting broader market trends. Earlier, they pulled back from a session low before recovering somewhat.

2026. g. 8. sept. 20:02 UTC

News

Citizens raised its price target on Progyny to $33, contributing to positive sentiment. The company reported Q2 revenues of $350.5 million.

2026. g. 3. sept. 20:07 UTC

News

Progyny Inc. shares are higher as CFO Mark Livingston prepares to present at the Wells Fargo Healthcare Conference on September 8, 2026.

2026. g. 2. sept. 20:08 UTC

Progyny Inc shares are higher today, continuing gains since Tuesday's close. The stock peaked earlier in the session before settling back.

2026. g. 1. sept. 23:41 UTC

Progyny Inc shares are higher in after-market hours, though no specific news was identified. The stock remains near its one-month range's lower end.

2026. g. 31. aug. 20:07 UTC

Progyny Inc. shares are lower as market sentiment shifts amid expectations of further interest rate hikes following the Jackson Hole Economic Symposium.

2026. g. 26. aug. 20:08 UTC

Progyny Inc shares are higher during Wednesday's session, continuing a notable gain since Tuesday. The stock remains below its 20-day moving average.

2026. g. 25. aug. 19:36 UTC

News

Progyny Inc. shares are advancing after reporting Q2 revenue growth of 5.3% and projecting full-year revenue between $1.36 billion and $1.385 billion.

2026. g. 24. aug. 19:36 UTC

Progyny Inc shares are lower today, reversing from earlier gains amid market volatility linked to geopolitical tensions and US sanctions against Iran.

2026. g. 20. aug. 19:31 UTC

News

Wells Fargo initiated coverage on Progyny Inc with an Overweight rating and a $37.00 price target, contributing to the stock's rise during Thursday's session.

2026. g. 18. aug. 20:06 UTC

Progyny Inc. shares are higher today, reflecting steady gains during the session. The stock remains below its 20-day moving average.

2026. g. 17. aug. 20:01 UTC

News

Progyny Inc shares are lower following a negative market reaction to its second-quarter earnings and lowered full-year revenue guidance to $1.37 billion.

2026. g. 14. aug. 20:06 UTC

Progyny Inc shares are higher during Friday's session, despite a recent pullback from earlier highs. Broader market sentiment remains mixed amid declining U.S. retail sales.

2026. g. 13. aug. 21:31 UTC

Progyny Inc shares are higher in after-market trading, recovering from earlier losses. No specific news was identified to explain the price movement.

2026. g. 12. aug. 20:01 UTC

News

Progyny Inc shares are lower following a Barclays downgrade, which cut the price target to $30 from $34, citing performance concerns.

2026. g. 11. aug. 20:02 UTC

News

Progyny Inc's stock is declining after a disappointing revenue forecast, despite strong second-quarter results that exceeded analyst expectations.

2026. g. 7. aug. 20:02 UTC

News

Progyny Inc's shares are lower after a cautious Q3 sales outlook, despite reporting revenue of $350.5 million that exceeded analyst expectations.

2026. g. 6. aug. 23:02 UTC

News

Progyny Inc shares are lower in after-market trading following a revenue guidance cut to $1.36 billion to $1.39 billion, below previous estimates.

2026. g. 31. jūl. 19:46 UTC

Progyny Inc shares are lower today amid broader market pressures and rising bond yields. No specific company news was identified to explain the decline.

2026. g. 30. jūl. 21:02 UTC

Progyny Inc shares are lower in after-market hours, with no specific news identified for the decline. The stock is below its 20-day moving average.

2026. g. 29. jūl. 18:55 UTC

Progyny Inc shares are higher today, reflecting notable strength in trading. The stock remains above its 20-day moving average.

2026. g. 28. jūl. 17:41 UTC

News
Social Media

Progyny Inc shares are lower following a downgrade by Barclays, which noted slowing website traffic growth at fertility clinics. Price target raised to $34 from $27.

2026. g. 24. jūl. 15:06 UTC

News

BTIG maintained its Buy rating on Progyny and raised the price target to $40. Shares are trading higher, remaining above the 20-day moving average.

2026. g. 22. jūl. 20:01 UTC

News

Progyny Inc shares are lower despite the acceptance of benefits at Pinnacle Fertility New York, enhancing access to reproductive care for members.

2026. g. 20. jūl. 17:16 UTC

Progyny Inc shares are higher today, maintaining a position near their one-month trading range. No specific news was identified to explain the movement.

Salīdzinājums

Cenas izmaiņa

Progyny Inc Prognoze

Cenas mērķis

By TipRanks

24.98% augšup

Prognoze 12 mēnešiem

Vidējais 34.182 USD  24.98%

Augstākais 40 USD

Zemākais 30 USD

Pamatojoties uz 11 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Progyny Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

11 ratings

9

Pirkt

2

Turēt

0

Pārdot

Noskaņojums

By Acuity

96 / 339 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
help-icon Live chat